antipsychotics

Latest

antipsychotics

·April 15, 2022·2 min read

Managing Excessive Weight Gain in Patients Being Treated With Antipsychotics

Researchers say 80% of people taking antipsychotics to manage schizophrenia or bipolar disorder experience considerable weight gain. Some patients report up to 33kg of weight gain following taking antipsychotic medications. A new study aims to explore ways of managing weight gain for patients taking antipsychotics.

Featured Genetics Neuroscience Psychology

·May 19, 2021·5 min read

Flies With Schizophrenia-Associated Genes Respond Well to Anti-Psychotics

Flies without the Rim gene or cac Cav2 channel function displayed numerous cognitive and behavioral deficits associated with schizophrenia, and had reductions in synaptic growth and neural calcium transients. Exposing the flies with Rim deficits to the common antipsychotic haloperidol reduced some of the schizophrenia-related behavioral symptoms.

Featured Neuroscience Open Neuroscience Articles Psychology

·May 12, 2021·4 min read

Brain Immune System Linked to Psychosis

A link has been identified between psychosis and a genetic change that alters the immune system in the brain. Researchers found people with psychosis associated with bipolar disorder had decreased expression of GRK3. This led to an increased amount of kynurenic acid in the brain.

Featured Neuroscience Psychology

·February 1, 2021·4 min read

Antipsychotic Prescriptions Rising Much Faster Than Psychosis Rates

While England has only seen a moderate rise in people being diagnosed with psychosis in recent years, prescription rates for antipsychotic medications have doubled.

Featured Genetics Neuroscience Open Neuroscience Articles Psychology

·January 30, 2021·4 min read

Why Do Psychiatric Drugs Help Some, but Not Others?

Study reveals the function of a specific protein works differently in the brains of men and women. The findings help explain why some psychiatric disorders and resistance to treatments vary between the sexes.

Featured Open Neuroscience Articles Psychology

·September 30, 2020·4 min read

Antipsychotics for Treating Adult Depression Linked With Higher Mortality

Study reveals a link between people with depression who are prescribed newer antipsychotic medications and higher mortality risk.

Featured Neuroscience Psychology

·June 14, 2020·2 min read

Clozapine may cause obsessions and compulsions

The antipsychotic medication clozapine can trigger severe obsessive-compulsive symptoms (OCS) in patients. Adding aripiprazole can help manage clozapine-associated OCS.

Featured Neuroscience Open Neuroscience Articles Psychology

·February 26, 2020·4 min read

Anti-psychotic medication linked to adverse change in brain structure

Sustained use of the antipsychotic olanzapine resulted in potentially adverse alterations in brain structure, specifically cortical thinning.

Featured Neuroscience Psychology

·February 12, 2020·4 min read

Early treatment of schizophrenia may not slow disease progression

Typical interventions for schizophrenia do not improve long-term outcomes, even when administered early, a new study reports.

Featured Neuroscience Psychology

·January 29, 2020·4 min read

How CBD takes effect in the brains of people with psychosis

During memory tasks, people with psychosis have different patterns of activity in the prefrontal and mediotemporal brain areas compared to those without the disorder. When exposed to cannabidiol (CBD), the activity of the brain areas became more like those seen in the controls for people with psychosis. Patients reported a decrease in symptoms of psychosis following one dose of CBD. Researchers stress that no definitive conclusions could be made about the effectiveness of CBD use over a sustained period.

Featured Neurology Neuroscience

·January 16, 2020·3 min read

Antipsychotics associated with increased risk of head & brain injuries in persons with Alzheimer’s disease

Alzheimer's patients who used antipsychotics had a 29% increased risk of head injury and a 22% higher risk of TBI compared to others with the neurodegenerative disease who did not use the medications.